Art
J-GLOBAL ID:200902117168167799
Reference number:02A0090491
Long-Term Effects of Olmesartan, an Ang II Receptor Antagonist, on Blood Pressure and the Renin-Angiotensin-Aldosterone System in Hypertensive Patients.
高血圧症患者における血圧とレニン-アンジオテンシン-アルドステロン系に与えるAng II受容体アンタゴニスト,オルメサルタンの長期効果
Author (2):
,
Material:
Volume:
24
Issue:
6
Page:
641-646
Publication year:
Nov. 2001
JST Material Number:
Y0303A
ISSN:
0916-9636
Document type:
Article
Article type:
原著論文
Country of issue:
Germany, Federal Republic of (DEU)
Language:
ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
JST classification (2):
JST classification
Category name(code) classified by JST.
Clinical application of vasoactive drugs and hypotensive drugs
, Drug therapy(=pharmacotherapy)for cardiovascular system diseases
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (20):
-
1. Timmermans PB: Ang II receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res 1999; 22: 147-153.
-
2. Mizuno M, Sada T, Ikeda M, et al: Pharmacology of CS-866, a novel nonpeptide Ang II receptor antagonist. Eur J Pharmacol 1995; 285: 181-188.
-
3. Yanagisawa H, Amemiya Y, Kanazaki T, et al: Nonpeptide Ang II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds. J Med Chem 1996; 39: 323-338.
-
4. Neutel JM: Clinical studies of CS-866, the newest angiotensin II receptor antagonist. Am J Cardiol 2000; 87: 37-43.
-
5. Puchler K, Nussberger J, Laeis P, Witte PU, Brunner HR: Blood pressure and endocrine effects of single doses of CS-866, a novel Ang II antagonist, in salt-restricted hypertensive patients. J Hypertens 1997; 15: 1809-1812.
more...
Terms in the title (7):
Terms in the title
Keywords automatically extracted from the title.
,
,
,
,
,
,
Return to Previous Page